Table 3. Open in new tab Proportions of... | Oxford Academic

Table 3.

Open in new tab

Proportions of first-line and non-first-line antibiotics prescribed for pharyngitis and sinusitis

	FY 2012	FY 2013	FY 2014	FY 2015	FY 2016	FY 2017	FY 2018	FY 2019	FY 2020
Pharyngitis (%)
First-line agent (penicillins)	7.7	8.0	8.5	8.5	8.7	10.0	11.7	13.5	16.2
Non-first-line agent
Third cephem	42.9	43.3	43.5	42.8	41.5	40.9	39.2	37.4	38.0
Macrolides	27.6	26.9	26.4	26.9	28.2	27.5	26.9	26.8	23.0
Quinolones	18.1	18.3	18.2	18.6	18.3	18.6	19.2	19.2	19.1
Others	3.8	3.5	3.4	3.2	3.2	3.0	3.0	3.2	3.7
Sinusitis (%)
First-line agent (penicillins)	10.5	10.7	10.8	10.5	11.1	12.1	13.9	15.8	16.5
Non-first-line agent
Macrolides	37.1	36.3	35.7	35.6	35.6	35.2	35.1	35.0	37.4
Third cephems	33.6	33.6	33.7	33.4	32.6	31.7	30.0	28.1	26.6
Quinolones	15.4	16.2	16.5	17.3	17.7	18.3	18.4	18.8	16.9
Others	3.3	3.3	3.2	3.2	3.0	2.7	2.5	2.4	2.6

	FY 2012	FY 2013	FY 2014	FY 2015	FY 2016	FY 2017	FY 2018	FY 2019	FY 2020
Pharyngitis (%)
First-line agent (penicillins)	7.7	8.0	8.5	8.5	8.7	10.0	11.7	13.5	16.2
Non-first-line agent
Third cephem	42.9	43.3	43.5	42.8	41.5	40.9	39.2	37.4	38.0
Macrolides	27.6	26.9	26.4	26.9	28.2	27.5	26.9	26.8	23.0
Quinolones	18.1	18.3	18.2	18.6	18.3	18.6	19.2	19.2	19.1
Others	3.8	3.5	3.4	3.2	3.2	3.0	3.0	3.2	3.7
Sinusitis (%)
First-line agent (penicillins)	10.5	10.7	10.8	10.5	11.1	12.1	13.9	15.8	16.5
Non-first-line agent
Macrolides	37.1	36.3	35.7	35.6	35.6	35.2	35.1	35.0	37.4
Third cephems	33.6	33.6	33.7	33.4	32.6	31.7	30.0	28.1	26.6
Quinolones	15.4	16.2	16.5	17.3	17.7	18.3	18.4	18.8	16.9
Others	3.3	3.3	3.2	3.2	3.0	2.7	2.5	2.4	2.6

FY, fiscal year; Third cephem, third-generation cephalosporins.

Table 3.

Open in new tab

Proportions of first-line and non-first-line antibiotics prescribed for pharyngitis and sinusitis

	FY 2012	FY 2013	FY 2014	FY 2015	FY 2016	FY 2017	FY 2018	FY 2019	FY 2020
Pharyngitis (%)
First-line agent (penicillins)	7.7	8.0	8.5	8.5	8.7	10.0	11.7	13.5	16.2
Non-first-line agent
Third cephem	42.9	43.3	43.5	42.8	41.5	40.9	39.2	37.4	38.0
Macrolides	27.6	26.9	26.4	26.9	28.2	27.5	26.9	26.8	23.0
Quinolones	18.1	18.3	18.2	18.6	18.3	18.6	19.2	19.2	19.1
Others	3.8	3.5	3.4	3.2	3.2	3.0	3.0	3.2	3.7
Sinusitis (%)
First-line agent (penicillins)	10.5	10.7	10.8	10.5	11.1	12.1	13.9	15.8	16.5
Non-first-line agent
Macrolides	37.1	36.3	35.7	35.6	35.6	35.2	35.1	35.0	37.4
Third cephems	33.6	33.6	33.7	33.4	32.6	31.7	30.0	28.1	26.6
Quinolones	15.4	16.2	16.5	17.3	17.7	18.3	18.4	18.8	16.9
Others	3.3	3.3	3.2	3.2	3.0	2.7	2.5	2.4	2.6

	FY 2012	FY 2013	FY 2014	FY 2015	FY 2016	FY 2017	FY 2018	FY 2019	FY 2020
Pharyngitis (%)
First-line agent (penicillins)	7.7	8.0	8.5	8.5	8.7	10.0	11.7	13.5	16.2
Non-first-line agent
Third cephem	42.9	43.3	43.5	42.8	41.5	40.9	39.2	37.4	38.0
Macrolides	27.6	26.9	26.4	26.9	28.2	27.5	26.9	26.8	23.0
Quinolones	18.1	18.3	18.2	18.6	18.3	18.6	19.2	19.2	19.1
Others	3.8	3.5	3.4	3.2	3.2	3.0	3.0	3.2	3.7
Sinusitis (%)
First-line agent (penicillins)	10.5	10.7	10.8	10.5	11.1	12.1	13.9	15.8	16.5
Non-first-line agent
Macrolides	37.1	36.3	35.7	35.6	35.6	35.2	35.1	35.0	37.4
Third cephems	33.6	33.6	33.7	33.4	32.6	31.7	30.0	28.1	26.6
Quinolones	15.4	16.2	16.5	17.3	17.7	18.3	18.4	18.8	16.9
Others	3.3	3.3	3.2	3.2	3.0	2.7	2.5	2.4	2.6

FY, fiscal year; Third cephem, third-generation cephalosporins.